Literature DB >> 27137453

New Anti-Schistosoma Approaches in The People's Republic of China: Development of Diagnostics, Vaccines and Other New Techniques Belonging to the 'Omics' Group.

S-B Chen1, L Ai1, W Hu2, J Xu1, R Bergquist3, Z-Q Qin1, J-H Chen1.   

Abstract

A new national schistosomiasis elimination programme will be implemented for the period 2016-20. To support this approach, we have performed a systematic review to assess anti-schistosome approaches in The People's Republic of China and defined research priorities for the coming years. A systematic search was conducted for articles published from January 2000 to March 2015 in international journals. Totally 410 references were published in English between 2000 and 2015 related to schistosomiasis after unrelated references and reviews or comments were further excluded. A set of research priorities has been identified for the near future that would improve the progress toward schistosomiasis elimination in The People's Republic of China. In particular, there is a lack of sensitive and specific tests for the detection of schistosomiasis cases with low parasite burdens, as well as an effective vaccine against schistosomiasis, and there is a need for surveillance tools that can evaluate the epidemic status for guiding the elimination strategy. Hence, we think that schistosomiasis control and elimination will be improved in The People's Republic of China through development of new tools.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Omics; Schistosoma; Schistosomiasis; The People's Republic of China; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27137453     DOI: 10.1016/bs.apar.2016.02.007

Source DB:  PubMed          Journal:  Adv Parasitol        ISSN: 0065-308X            Impact factor:   3.870


  7 in total

Review 1.  History of Human Schistosomiasis (bilharziasis) in China: From Discovery to Elimination.

Authors:  Yibiao Zhou; Yue Chen; Qingwu Jiang
Journal:  Acta Parasitol       Date:  2021-03-13       Impact factor: 1.440

2.  Reliability of heterophyid antigens in heterologous protection against human schistosomiasis.

Authors:  Alaa H A Hegazy; Lamia A Galal; Tasneem M Hassan; Refaat M A Khalifa
Journal:  J Parasit Dis       Date:  2020-01-24

3.  Tropical Medicine in China: Bibliometric Analysis Based on Web of Science (2010-2019).

Authors:  Zhen Li; Jingbo Xue; Bin Zheng
Journal:  J Trop Med       Date:  2021-08-10

Review 4.  Differentiating snail intermediate hosts of Schistosoma spp. using molecular approaches: fundamental to successful integrated control mechanism in Africa.

Authors:  Eniola Michael Abe; Wei Guan; Yun-Hai Guo; Kokouvi Kassegne; Zhi-Qiang Qin; Jing Xu; Jun-Hu Chen; Uwem Friday Ekpo; Shi-Zhu Li; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2018-03-26       Impact factor: 4.520

5.  Effects of Polymorphisms in the SjSP-13 Gene of Schistosoma japonicum on Its Diagnostic Efficacy and Immunogenicity.

Authors:  Xindong Xu; Xiaobing Cui; Liufang Zhu; Zhengli Li; Yuanbin Zhang; Li Ma; Weiqing Pan
Journal:  Front Microbiol       Date:  2018-07-25       Impact factor: 5.640

6.  Study roadmap for high-throughput development of easy to use and affordable biomarkers as diagnostics for tropical diseases: a focus on malaria and schistosomiasis.

Authors:  Kokouvi Kassegne; Ting Zhang; Shen-Bo Chen; Bin Xu; Zhi-Sheng Dang; Wang-Ping Deng; Eniola Michael Abe; Hai-Mo Shen; Wei Hu; Takele Geressu Guyo; Solomon Nwaka; Jun-Hu Chen; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2017-10-02       Impact factor: 4.520

Review 7.  Policy Support and Resources Mobilization for the National Schistosomiasis Control Programme in The People's Republic of China.

Authors:  H Zhu; P Yap; J Utzinger; T-W Jia; S-Z Li; X-B Huang; S-X Cai
Journal:  Adv Parasitol       Date:  2016-04-16       Impact factor: 3.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.